Fennec Pharmaceuticals (FENC) Begins Rolling NDA for PEDMARKTM Following Pre-Submission Meeting with FDA
Tweet Send to a Friend
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) following a pre-submission meeting with the oncology division of the U.S. Food and Drug Administration ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
